Table 2.
(i) Availability of versatile carriers | |
(ii) Protection to drug molecules | |
(iii) Biocompatible | |
(iv) Interaction with skin components | |
(v) Loading of variety of drugs | |
(vi) Modification in physiochemical properties | |
(vii) Intact penetration | |
(viii) Passive targeting |